Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMBRIEL phase 2b trial of tozorakimab in adults with uncontrolled asthma
MOH_2025-02-27_013946Phase 2Recruiting
- Sponsor
- AstraZeneca
- Start
- Feb 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tozorakimab in asthma (3 arms), sponsored by AstraZeneca. Started Feb 2025; status: recruiting.
02
Drugs
tozorakimab
03
Conditions
asthma
Beyond the preview
Go deeper on MOH_2025-02-27_013946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-02-27_013946.